Does neuroinflammation fan the flame in neurodegenerative diseases?
Open Access
- 16 November 2009
- journal article
- Published by Springer Science and Business Media LLC in Molecular Neurodegeneration
- Vol. 4 (1), 47
- https://doi.org/10.1186/1750-1326-4-47
Abstract
While peripheral immune access to the central nervous system (CNS) is restricted and tightly controlled, the CNS is capable of dynamic immune and inflammatory responses to a variety of insults. Infections, trauma, stroke, toxins and other stimuli are capable of producing an immediate and short lived activation of the innate immune system within the CNS. This acute neuroinflammatory response includes activation of the resident immune cells (microglia) resulting in a phagocytic phenotype and the release of inflammatory mediators such as cytokines and chemokines. While an acute insult may trigger oxidative and nitrosative stress, it is typically short-lived and unlikely to be detrimental to long-term neuronal survival. In contrast, chronic neuroinflammation is a long-standing and often self-perpetuating neuroinflammatory response that persists long after an initial injury or insult. Chronic neuroinflammation includes not only long-standing activation of microglia and subsequent sustained release of inflammatory mediators, but also the resulting increased oxidative and nitrosative stress. The sustained release of inflammatory mediators works to perpetuate the inflammatory cycle, activating additional microglia, promoting their proliferation, and resulting in further release of inflammatory factors. Neurodegenerative CNS disorders, including multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), tauopathies, and age-related macular degeneration (ARMD), are associated with chronic neuroinflammation and elevated levels of several cytokines. Here we review the hallmarks of acute and chronic inflammatory responses in the CNS, the reasons why microglial activation represents a convergence point for diverse stimuli that may promote or compromise neuronal survival, and the epidemiologic, pharmacologic and genetic evidence implicating neuroinflammation in the pathophysiology of several neurodegenerative diseases.Keywords
This publication has 128 references indexed in Scilit:
- Developing novel immunogens for a safe and effective Alzheimer's disease vaccinePublished by Elsevier BV ,2009
- Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsMolecular Therapy, 2008
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's diseaseThe Journal of Experimental Medicine, 2008
- Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences of the United States of America, 2006
- Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degenerationNeurobiology of Disease, 2005
- Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosisGlia, 2005
- Neuroinflammation in Alzheimer's disease and prion diseaseGlia, 2002
- Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementiaNeurobiology of Aging, 1995
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991